Fed. Circ. Sends Xencor Antibody Patent Case Back To USPTO
The Federal Circuit has granted the U.S. Patent and Trademark Office's bid to send Xencor Inc.'s application for an antibody patent back for further proceedings to a new administrative appellate panel....To view the full article, register now.
Already a subscriber? Click here to view full article